Clinical Trial: Urinary PGE-MUM as a Marker for Ulcerative Colitis Activity

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07637045) titled 'Urinary PGE-MUM as a Marker for Ulcerative Colitis Activity' on June 04.

Brief Summary: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that requires regular monitoring of disease activity. Currently, assessment depends on invasive colonoscopy or clinical scores that may not accurately reflect intestinal inflammation. This study aims to evaluate whether urinary Prostaglandin E-Major Metabolite (PGE-MUM) can serve as a non-invasive biomarker to discriminate disease activity in patients with ulcerative colitis.

This cross-sectional study will be conducted at Al-Rajhi University Hospital, Assiut University, Egypt. We p...